Selected research
Market Structure
Global Statin Industry Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Statin Industry market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Statin Industry is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Statin Industry is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Statin Industry is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Statin Industry is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Statin Industry include CHIA TAI TIANQING, Zhejiang Jingxin Pharmaceutical, Shanghai Shyndec Pharmaceutical, Henan Topfond Pharmaceutical, Novartis, Merck, LUNAN BETTER, Livzon Pharmaceutical and Wanbang Biopharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Statin Industry market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Statin Industry and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Statin Industry revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Statin Industry market size, projected growth trends, production technologies, key applications, and end-use industries.
Statin Industry Segment by Company
CHIA TAI TIANQING
Zhejiang Jingxin Pharmaceutical
Shanghai Shyndec Pharmaceutical
Henan Topfond Pharmaceutical
Novartis
Merck
LUNAN BETTER
Livzon Pharmaceutical
Wanbang Biopharmaceuticals
Pfizer
Huizhi
China Resources Double-Crane Pharmaceutical
North China Pharmaceutical
Hanhui Pharmaceutical
Daiichi Sankyo
Beijing Jialin Pharmaceutical
AstraZeneca
Statin Industry Segment by Type
Astrovastatin
Pitavastatin
Rosuvastatin
Others
Statin Industry Segment by Application
Inflammatory Disorders
Cardiovascular Disorders
Obesity
Others
Statin Industry Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Statin Industry market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Statin Industry and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Statin Industry.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Statin Industry in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Statin Industry industry.
Chapter 3: Detailed analysis of Statin Industry companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Statin Industryrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Astrovastatin
- Pitavastatin
- Rosuvastatin
- Others
Applications
- Inflammatory Disorders
- Cardiovascular Disorders
- Obesity
- Others
Companies covered
- CHIA TAI TIANQING
- Zhejiang Jingxin Pharmaceutical
- Shanghai Shyndec Pharmaceutical
- Henan Topfond Pharmaceutical
- Novartis
- Merck
- LUNAN BETTER
- Livzon Pharmaceutical
- Wanbang Biopharmaceuticals
- Pfizer
- Huizhi
- China Resources Double-Crane Pharmaceutical
- North China Pharmaceutical
- Hanhui Pharmaceutical
- Daiichi Sankyo
- Beijing Jialin Pharmaceutical
- AstraZeneca
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Statin Industry Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Astrovastatin
- 1.2.3 Pitavastatin
- 1.2.4 Rosuvastatin
- 1.2.5 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global Statin Industry Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Inflammatory Disorders
- 1.3.3 Cardiovascular Disorders
- 1.3.4 Obesity
- 1.3.5 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Statin Industry Growth Trends by Region
- 1.5.1 Global Statin Industry Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Statin Industry Market Size by Region (2021-2026)
- 1.5.3 Statin Industry Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Statin Industry Market Dynamics
- 2.1 Statin Industry Industry Trends
- 2.2 Statin Industry Industry Drivers
- 2.3 Statin Industry Industry Opportunities and Challenges
- 2.4 Statin Industry Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Statin Industry Revenue by Company (2021-2026)
- 3.2 Global Statin Industry Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Statin Industry Key Company Head office and Area Served
- 3.4 Global Statin Industry Company, Product Type & Application
- 3.5 Global Statin Industry Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Statin Industry Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Statin Industry Players Market Share by Revenue in 2025
- 3.6.3 2025 Statin Industry Tier 1, Tier 2, and Tier 3
4 Statin Industry Market by Type
- 4.1 Global Statin Industry Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Statin Industry Market Size by Type (2021-2032)
- 4.3 Global Statin Industry Market Size Share by Type (2021-2032)
5 Statin Industry Market by Application
- 5.1 Global Statin Industry Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Statin Industry Market Size by Application (2021-2032)
- 5.3 Global Statin Industry Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 CHIA TAI TIANQING
- 6.1.1 CHIA TAI TIANQING Company Information
- 6.1.2 CHIA TAI TIANQING Business Overview
- 6.1.3 CHIA TAI TIANQING Statin Industry Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 CHIA TAI TIANQING Statin Industry Product Portfolio
- 6.1.5 CHIA TAI TIANQING Recent Developments
- 6.2 Zhejiang Jingxin Pharmaceutical
- 6.2.1 Zhejiang Jingxin Pharmaceutical Company Information
- 6.2.2 Zhejiang Jingxin Pharmaceutical Business Overview
- 6.2.3 Zhejiang Jingxin Pharmaceutical Statin Industry Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Zhejiang Jingxin Pharmaceutical Statin Industry Product Portfolio
- 6.2.5 Zhejiang Jingxin Pharmaceutical Recent Developments
- 6.3 Shanghai Shyndec Pharmaceutical
- 6.3.1 Shanghai Shyndec Pharmaceutical Company Information
- 6.3.2 Shanghai Shyndec Pharmaceutical Business Overview
- 6.3.3 Shanghai Shyndec Pharmaceutical Statin Industry Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Shanghai Shyndec Pharmaceutical Statin Industry Product Portfolio
- 6.3.5 Shanghai Shyndec Pharmaceutical Recent Developments
- 6.4 Henan Topfond Pharmaceutical
- 6.4.1 Henan Topfond Pharmaceutical Company Information
- 6.4.2 Henan Topfond Pharmaceutical Business Overview
- 6.4.3 Henan Topfond Pharmaceutical Statin Industry Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Henan Topfond Pharmaceutical Statin Industry Product Portfolio
- 6.4.5 Henan Topfond Pharmaceutical Recent Developments
- 6.5 Novartis
- 6.5.1 Novartis Company Information
- 6.5.2 Novartis Business Overview
- 6.5.3 Novartis Statin Industry Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Novartis Statin Industry Product Portfolio
- 6.5.5 Novartis Recent Developments
- 6.6 Merck
- 6.6.1 Merck Company Information
- 6.6.2 Merck Business Overview
- 6.6.3 Merck Statin Industry Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Merck Statin Industry Product Portfolio
- 6.6.5 Merck Recent Developments
- 6.7 LUNAN BETTER
- 6.7.1 LUNAN BETTER Company Information
- 6.7.2 LUNAN BETTER Business Overview
- 6.7.3 LUNAN BETTER Statin Industry Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 LUNAN BETTER Statin Industry Product Portfolio
- 6.7.5 LUNAN BETTER Recent Developments
- 6.8 Livzon Pharmaceutical
- 6.8.1 Livzon Pharmaceutical Company Information
- 6.8.2 Livzon Pharmaceutical Business Overview
- 6.8.3 Livzon Pharmaceutical Statin Industry Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Livzon Pharmaceutical Statin Industry Product Portfolio
- 6.8.5 Livzon Pharmaceutical Recent Developments
- 6.9 Wanbang Biopharmaceuticals
- 6.9.1 Wanbang Biopharmaceuticals Company Information
- 6.9.2 Wanbang Biopharmaceuticals Business Overview
- 6.9.3 Wanbang Biopharmaceuticals Statin Industry Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Wanbang Biopharmaceuticals Statin Industry Product Portfolio
- 6.9.5 Wanbang Biopharmaceuticals Recent Developments
- 6.10 Pfizer
- 6.10.1 Pfizer Company Information
- 6.10.2 Pfizer Business Overview
- 6.10.3 Pfizer Statin Industry Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Pfizer Statin Industry Product Portfolio
- 6.10.5 Pfizer Recent Developments
- 6.11 Huizhi
- 6.11.1 Huizhi Company Information
- 6.11.2 Huizhi Business Overview
- 6.11.3 Huizhi Statin Industry Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Huizhi Statin Industry Product Portfolio
- 6.11.5 Huizhi Recent Developments
- 6.12 China Resources Double-Crane Pharmaceutical
- 6.12.1 China Resources Double-Crane Pharmaceutical Company Information
- 6.12.2 China Resources Double-Crane Pharmaceutical Business Overview
- 6.12.3 China Resources Double-Crane Pharmaceutical Statin Industry Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 China Resources Double-Crane Pharmaceutical Statin Industry Product Portfolio
- 6.12.5 China Resources Double-Crane Pharmaceutical Recent Developments
- 6.13 North China Pharmaceutical
- 6.13.1 North China Pharmaceutical Company Information
- 6.13.2 North China Pharmaceutical Business Overview
- 6.13.3 North China Pharmaceutical Statin Industry Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 North China Pharmaceutical Statin Industry Product Portfolio
- 6.13.5 North China Pharmaceutical Recent Developments
- 6.14 Hanhui Pharmaceutical
- 6.14.1 Hanhui Pharmaceutical Company Information
- 6.14.2 Hanhui Pharmaceutical Business Overview
- 6.14.3 Hanhui Pharmaceutical Statin Industry Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Hanhui Pharmaceutical Statin Industry Product Portfolio
- 6.14.5 Hanhui Pharmaceutical Recent Developments
- 6.15 Daiichi Sankyo
- 6.15.1 Daiichi Sankyo Company Information
- 6.15.2 Daiichi Sankyo Business Overview
- 6.15.3 Daiichi Sankyo Statin Industry Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Daiichi Sankyo Statin Industry Product Portfolio
- 6.15.5 Daiichi Sankyo Recent Developments
- 6.16 Beijing Jialin Pharmaceutical
- 6.16.1 Beijing Jialin Pharmaceutical Company Information
- 6.16.2 Beijing Jialin Pharmaceutical Business Overview
- 6.16.3 Beijing Jialin Pharmaceutical Statin Industry Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 Beijing Jialin Pharmaceutical Statin Industry Product Portfolio
- 6.16.5 Beijing Jialin Pharmaceutical Recent Developments
- 6.17 AstraZeneca
- 6.17.1 AstraZeneca Company Information
- 6.17.2 AstraZeneca Business Overview
- 6.17.3 AstraZeneca Statin Industry Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.17.4 AstraZeneca Statin Industry Product Portfolio
- 6.17.5 AstraZeneca Recent Developments
7 North America
- 7.1 North America Statin Industry Market Size (2021-2032)
- 7.2 North America Statin Industry Market Size by Type
- 7.2.1 North America Statin Industry Market Size by Type (2021-2026)
- 7.2.2 North America Statin Industry Market Size by Type (2027-2032)
- 7.2.3 North America Statin Industry Market Share by Type (2021-2032)
- 7.3 North America Statin Industry Market Size by Application
- 7.3.1 North America Statin Industry Market Size by Application (2021-2026)
- 7.3.2 North America Statin Industry Market Size by Application (2027-2032)
- 7.3.3 North America Statin Industry Market Share by Application (2021-2032)
- 7.4 North America Statin Industry Market Size by Country
- 7.4.1 North America Statin Industry Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Statin Industry Market Size by Country (2021-2026)
- 7.4.3 North America Statin Industry Market Size by Country (2027-2032)
- 7.4.4 North America Statin Industry Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Statin Industry Market Size (2021-2032)
- 8.2 Europe Statin Industry Market Size by Type
- 8.2.1 Europe Statin Industry Market Size by Type (2021-2026)
- 8.2.2 Europe Statin Industry Market Size by Type (2027-2032)
- 8.2.3 Europe Statin Industry Market Share by Type (2021-2032)
- 8.3 Europe Statin Industry Market Size by Application
- 8.3.1 Europe Statin Industry Market Size by Application (2021-2026)
- 8.3.2 Europe Statin Industry Market Size by Application (2027-2032)
- 8.3.3 Europe Statin Industry Market Share by Application (2021-2032)
- 8.4 Europe Statin Industry Market Size by Country
- 8.4.1 Europe Statin Industry Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Statin Industry Market Size by Country (2021-2026)
- 8.4.3 Europe Statin Industry Market Size by Country (2027-2032)
- 8.4.4 Europe Statin Industry Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Statin Industry Market Size (2021-2032)
- 9.2 China Statin Industry Market Size by Type
- 9.2.1 China Statin Industry Market Size by Type (2021-2026)
- 9.2.2 China Statin Industry Market Size by Type (2027-2032)
- 9.2.3 China Statin Industry Market Share by Type (2021-2032)
- 9.3 China Statin Industry Market Size by Application
- 9.3.1 China Statin Industry Market Size by Application (2021-2026)
- 9.3.2 China Statin Industry Market Size by Application (2027-2032)
- 9.3.3 China Statin Industry Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Statin Industry Market Size (2021-2032)
- 10.2 Asia Statin Industry Market Size by Type
- 10.2.1 Asia Statin Industry Market Size by Type (2021-2026)
- 10.2.2 Asia Statin Industry Market Size by Type (2027-2032)
- 10.2.3 Asia Statin Industry Market Share by Type (2021-2032)
- 10.3 Asia Statin Industry Market Size by Application
- 10.3.1 Asia Statin Industry Market Size by Application (2021-2026)
- 10.3.2 Asia Statin Industry Market Size by Application (2027-2032)
- 10.3.3 Asia Statin Industry Market Share by Application (2021-2032)
- 10.4 Asia Statin Industry Market Size by Country
- 10.4.1 Asia Statin Industry Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Statin Industry Market Size by Country (2021-2026)
- 10.4.3 Asia Statin Industry Market Size by Country (2027-2032)
- 10.4.4 Asia Statin Industry Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Statin Industry Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Statin Industry Market Size by Type
- 11.2.1 South America, Middle East & Africa Statin Industry Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Statin Industry Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Statin Industry Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Statin Industry Market Size by Application
- 11.3.1 South America, Middle East & Africa Statin Industry Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Statin Industry Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Statin Industry Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Statin Industry Market Size by Country
- 11.4.1 South America, Middle East & Africa Statin Industry Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Statin Industry Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Statin Industry Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Statin Industry Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst